<DOC>
	<DOCNO>NCT01738893</DOCNO>
	<brief_summary>The objective study confirm two formulation gabapentin ( capsule ) bioequivalent . Test product Darbetin® 300 mg ( Laboratorios Dermatológicos Darier ) reference product Nerotin® 300 mg ( Pfizer ) . One capsule single dosage . The study prospective , open-label , randomize , crossover , single dose , 02 treatment , 02 sequence 02 period , fast condition . The population compose 26 healthy volunteer , gender , adult 18-55 year . The comparative bioavailability two formulation evaluate base statistical comparison relevant pharmacokinetic parameter , obtain data drug concentration blood .</brief_summary>
	<brief_title>Bioequivalence Study 300 mg Gabapentin</brief_title>
	<detailed_description />
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Males 1855 year . Healthy base comprehensive medical history , lab test , Chest xray , Electrocardiogram , negative test Hepatitis B C , HIV . Negative urine dope test . BMI 1926.5 kg/m2 . Lab test normal range +/ 10 % . Blood pressure 13990/8950 , heart rate 10055 , respiratory rate 2417 , temperature 37.535 °C . Nonsmoking least 10 hr study . Written informed consent . Women must pregnant , breastfeed . Hypersensitivity study medication relate drug . History cardiovascular , renal , hepatic , metabolic , gastrointestinal , neurologic , endocrine , hematopoietic , psychiatric organic condition . Requiring drug interfere minocycline pharmacokinetics . Exposed inducer inhibitor hepatic enzyme . Intake possible toxic drug 30 day study . Intake drug 14 day 7 halflives study . Hospitalization severe disease 60 day study . Receiving investigational drug study center 30 day study . Blood loss blood donation = &gt; 450 ml 60 day study . Recent history drug abuse include alcohol . Intake xanthine containing product 10 hr study . Intake grapefruit juice hotspice 10 hr study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Gabapentin</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Mexico</keyword>
</DOC>